Lowell Farms Inc. Announces Record Revenues and Record Cultivation Output for the Second Quarter
Lowell Reports 37% sequential growth in revenue driven by large cultivation yields advances and strong…
Month: August 2021
Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update
Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0,…
Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative…
Eloxx Pharmaceuticals Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update
Added Additional Treatment Arm and Provided Enrollment Update for Ongoing ELX-02 Phase 2 Clinical Trials…
Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results
Announced first patient dosed in Phase 1 trial evaluating KIN-2787 in patients with BRAF mutation-positive solid…
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2021 and Business Highlights
Acumen’s investigational drug, ACU193, is the first humanized monoclonal antibody discovered and developed to selectively…
Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business Update
Sale of legacy business to Alora Pharmaceuticals, LLC expected to close in third quarter 2021…
Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
Top-line data from ongoing Phase 1 proof of concept clinical trial of TERN-501 expected in…
Eton Pharmaceuticals Reports Second Quarter Financial Results
DEER PARK, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), an…
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
– Initiated open label extension for LIFT-AD and ACT-AD trials of ATH-1017 allowing for an…
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
– Recently expanded Autoimmune franchise with advancement of third clinical candidate, ANX009, and strategically expanded…
Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results
DAVIS, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights
Net revenue for second quarter of 2021 increased 89% year-over-year to $17.8 million, a quarterly…
Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
CAMBRIDGE, Mass., Aug. 16, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage…
Verizon Authorized Retailer CellOnly Expands Southward, Acquires 14 Locations Across Texas and Oklahoma
Communication Connection locations join CellOnly’s footprint of 56 wireless retail stores AMARILLO, Texas, Aug. 16,…
ByteDance Joins the Open Invention Network
DURHAM, N.C., Aug. 17, 2021 (GLOBE NEWSWIRE) — Open Invention Network (OIN), the largest patent…
Independent Product Testing Firm Ten Mile Square Technologies Confirms INTRUSION Shield’s Cyber Defense Capabilities
PLANO, Texas, Aug. 16, 2021 (GLOBE NEWSWIRE) — INTRUSION, Inc. (Nasdaq: INTZ) today announced that…